Northstar Financial Companies’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
5,151
-788
-13% -$41.7K 0.18% 102
2026
Q1
$328K Sell
5,939
-300
-5% -$16.3K 0.26% 76
2025
Q4
$306K Sell
6,239
-160
-3% -$7.46K 0.24% 88
2025
Q3
$276K Sell
6,399
-336
-5% -$13.1K 0.26% 84
2025
Q2
$259K Hold
6,735
0.27% 88
2025
Q1
$261K Hold
6,735
0.28% 84
2024
Q4
$228K Buy
+6,735
New +$242K 0.22% 97

Other funds holding GSK

Northstar Financial Companies's GSK Position: Q2 2026 in Review

Northstar Financial Companies reduced its GSK (GSK) stake by 13% in Q2 2026, selling an estimated $41.7K and leaving 5,151 shares worth $270K. The position accounts for 0.18% of the portfolio, ranked #102.

Northstar Financial Companies first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $328K in Q1 2026. 576 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Northstar Financial Companies held 5,151 shares of GSK worth $270K as of Q2 2026.
  • Northstar Financial Companies sold 788 GSK shares in Q2 2026, an estimated $41.7K.
  • GSK made up 0.18% of Northstar Financial Companies's portfolio in Q2 2026, its #102 holding.
  • Northstar Financial Companies first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Northstar Financial Companies's GSK position peaked at $328K in Q1 2026.
  • 576 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Northstar Financial Companies's 13F filing for Q2 2026, filed 6 Aug 2026.